Radiation DosageRadiation, IonizingAntineoplastic Combined Chemotherapy ProtocolsRadiation InjuriesAntineoplastic AgentsDose-Response Relationship, RadiationRadiation ToleranceRadiationChemotherapy, AdjuvantRadiation ProtectionRadiation MonitoringCombined Modality TherapyDoxorubicinCisplatinNeoplasmsCell Line, TumorRadiation OncologyDrug Screening Assays, AntitumorRadiotherapyTreatment OutcomeCosmic RadiationRadiation Injuries, ExperimentalDrug Resistance, NeoplasmRadiation PneumonitisBreast NeoplasmsEtoposideGamma RaysCyclophosphamideRadiotherapy DosageApoptosisNeoplasms, Radiation-InducedAntineoplastic Agents, PhytogenicBackground RadiationPaclitaxelCell SurvivalAntibiotics, AntineoplasticRadiation-Sensitizing AgentsDisease-Free SurvivalRadiometryUltraviolet RaysNeoplasm StagingSurvival AnalysisNeoadjuvant TherapyDNA DamageRadiation EffectsTime FactorsLung NeoplasmsSurvival RatePrognosisRadiation-Protective AgentsTumor Cells, CulturedRadiotherapy, AdjuvantVinblastineAntimetabolites, AntineoplasticXenograft Model Antitumor AssaysCamptothecinDrug Administration ScheduleMice, NudeMethotrexateDrug Delivery SystemsNeoplasm Recurrence, LocalBleomycinCarboplatinOrganoplatinum CompoundsDose-Response Relationship, DrugBrain NeoplasmsAntineoplastic Agents, AlkylatingAdenocarcinomaTaxoidsRadiotherapy, ConformalAcute Radiation SyndromeDose FractionationDeoxycytidineCell ProliferationDrug CarriersCarcinoma, Non-Small-Cell LungX-RaysCobalt RadioisotopesRadiotherapy, Intensity-ModulatedP-GlycoproteinRadioactive Hazard ReleaseDrug Resistance, MultipleFollow-Up StudiesCarcinoma, Squamous CellDNA RepairClinical Trials as TopicHead and Neck NeoplasmsDaunorubicinRadiobiologyAnthracyclinesRadiation Hybrid MappingBrachytherapyCell CycleOvarian NeoplasmsDacarbazineNeoplasm MetastasisInduction ChemotherapyDrug SynergismMitomycinMitoxantrone